Evidence indicates that nuclear factor-kappa B (NF-κB), a transcription factor activated during inflammation, can regulate BACE1 transcription, thereby enhancing Aβ production and exacerbating AD pathology [47,48]. Here, NFKB1 is linked to Alzheimer disease.